Stay updated on Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No changes to study content or criteria are observed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedExpanded the study locations to include additional sites across the US and Canada (e.g., Alabama, Alaska, Ontario, Quebec). The revision was updated to v3.3.3.SummaryDifference2%

- Check35 days agoChange DetectedDifference0.1%

- Check56 days agoChange DetectedPublications are now described as automatically filled from PubMed with updated wording, the old PubMed sentence was removed, and a site revision tag 'Revision: v3.3.2' was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedRemoved the government funding status notice banner from the page; the study details and other core content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedNo significant content changes were detected between the two screenshots. The page still presents the same study details, eligibility criteria, and locations as before.SummaryDifference0.2%

Stay in the know with updates to Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.